Profile - To The Moon

Hodl

Posts · 231Posts · 231
Following · 0Following · 0
Followers · 0Followers · 0

- HodlHodl
  ·2022-02-17
  
  Moderna patent application raises fears for Africa COVID vaccine hub
  * Africa hub firm says patent will impede freedom to operate* Moderna says patents will not affect v
  Moderna patent application raises fears for Africa COVID vaccine hub
  630 Comment
  2
  Share
  Report
- HodlHodl
  ·2022-02-11
  
  Sorry, this post has been deleted
  713 1
  10
  Share
  Report
- HodlHodl
  ·2022-02-04
  
  Sorry, this post has been deleted
  735 Comment
  1
  Share
  Report
- HodlHodl
  ·2022-02-01
  
  Sorry, this post has been deleted
  714 Comment
  1
  Share
  Report
- HodlHodl
  ·2022-01-30
  
  Sorry, this post has been deleted
  983 Comment
  4
  Share
  Report
- HodlHodl
  ·2022-01-27
  
  Tesla Delays New Models in Bet Thin Lineup Can Ease Supply Woes
  Tesla Inc. pushed back introductions of new models to next year, wagering the best way to continue e
  Tesla Delays New Models in Bet Thin Lineup Can Ease Supply Woes
  917 1
  4
  Share
  Report
- HodlHodl
  ·2022-01-25
  
  Nvidia Quietly Prepares to Abandon Takeover of Arm
  Nvidia Corp.is quietly preparing to abandon its purchase of Arm Ltd.from SoftBank Group Corp.after m
  Nvidia Quietly Prepares to Abandon Takeover of Arm
  1.14K Comment
  6
  Share
  Report
- HodlHodl
  ·2022-01-24
  
  Peloton may be toast
  New York (CNN Business) - Peloton had a disastrous 2021. But as impossible as it may seem, the exerc
  Peloton may be toast
  1.17K Comment
  2
  Share
  Report
- HodlHodl
  ·2022-01-22
  
  Sorry, this post has been deleted
  859 Comment
  2
  Share
  Report
- HodlHodl
  ·2022-01-22
  
  US STOCKS-S&P 500, Nasdaq Post Worst Weeks since Pandemic Start as Netflix Woes Deepen Slide
  * Netflix plunges, weighs on Disney, media stocks* S&P 500, Nasdaq have biggest weekly drops since March 2020* Focus turning to Fed meeting for clarity on policy* Indexes down: Dow 1.3%, S&P 1.89%, Na
  US STOCKS-S&P 500, Nasdaq Post Worst Weeks since Pandemic Start as Netflix Woes Deepen Slide
  1.46K Comment
  3
  Share
  Report

抱歉，当前请求异常(-1)

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"3579666066637422","uuid":"3579666066637422","gmtCreate":1616581498902,"gmtModify":1623576741314,"name":"Hodl","pinyin":"hodl","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/d591a82f579d3114da9795812a4217a0","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":19,"headSize":501,"tweetSize":231,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":1,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.12.20","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"60.28%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":3,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":9094140215,"gmtCreate":1645096109601,"gmtModify":1676533996336,"author":{"id":"3579666066637422","authorId":"3579666066637422","name":"Hodl","avatar":"https://static.tigerbbs.com/d591a82f579d3114da9795812a4217a0","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579666066637422","authorIdStr":"3579666066637422"},"themes":[],"htmlText":"[Grin]&nbsp;","listText":"[Grin]&nbsp;","text":"[Grin]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9094140215","repostId":"2212613232","repostType":4,"repost":{"id":"2212613232","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1645095833,"share":"https://ttm.financial/m/news/2212613232?lang=&edition=full_marsco","pubTime":"2022-02-17 19:03","market":"us","language":"en","title":"Moderna patent application raises fears for Africa COVID vaccine hub","url":"https://stock-news.laohu8.com/highlight/detail?id=2212613232","media":"Reuters","summary":"* Africa hub firm says patent will impede freedom to operate* Moderna says patents will not affect v","content":"<html><head></head><body><p>* Africa hub firm says patent will impede freedom to operate</p><p>* Moderna says patents will not affect vaccine distribution</p><p>* Firm has pledged not to enforce mRNA patents during pandemic</p><p>* But charities fear it will, once COVID-19 is declared endemic</p><p>CAPE TOWN/CHICAGO, Feb 17 (Reuters) - Moderna Inc has applied for patents in South Africa relating to its COVID-19 vaccine, prompting fears the company could eventually seek to prevent a new African vaccine manufacturing hub from making its own version of the mRNA shot.</p><p>Moderna    spokesperson Colleen Hussey confirmed it had filed for patents \"related to both the COVID-19 vaccine and Moderna's platform technology\" in South Africa and elsewhere, after a group of 60 Africa-based charities raised concerns about them, but said the move would not block vaccine distribution in Africa.</p><p>She reiterated Moderna's October 2020 pledge not to enforce its COVID-19 related patents during the coronavirus pandemic.</p><p>But South Africa's Afrigen Biologics, which used the publicly available sequence of Moderna's vaccine to make its own version of the vaccine, said it had received no communication from the company about the patent filings.</p><p>It plans to start making and distributing across Africa in November.</p><p>Responding to a query if the company would enforce patents in Africa at the end of the pandemic, Chief Executive Stéphane Bancel told Reuters, \"We have not decided yet for low- and middle-income countries.\"</p><p>The charities fear it will enforce them when COVID-19 is declared endemic, Tian Johnson, founder of the African Alliance, said in a joint statement.</p><p>This \"would effectively derail all work the World Health Organization and African scientists have put into building vaccine manufacturing capacity on the continent,\" he added.</p><p>The Africa vaccine hub has WHO backing, as part of a pilot project to give poor and middle-income countries the know-how to make COVID-19 vaccines.</p><p>\"Moderna is committed to ... equitable access to vaccines and can confirm that its intellectual property will not create a barrier to COVID vaccine distribution in AMC-92 countries by Afrigen Biologics either now or in the future,\" Hussey said.</p><p>But Afrigen Chief Executive Petro Terblanche told Reuters in a text message, \"We have had no communication from Moderna ... We (would) ... truly value their collaboration.\"</p><p>\"There are patents filed in South Africa and other low-and-middle income countries by Moderna that, unless those are revoked, or voluntary licenses are awarded or Moderna will waive it, it will impact on our freedom to operate,\" she added.</p><p>On Wednesday, BioNTech's     co-founder and top executive told Reuters the vaccine maker had no plans to enforce its intellectual property rights should groups in Africa seek to make unauthorised versions of its shot.</p><p>For much of the pandemic, wealthy countries monopolised most of the global supplies of vaccines, leaving Africa massively under-vaccinated, with just <a href=\"https://laohu8.com/S/AONE.U\">one</a> in ten Africans immunised.</p><p>Poor domestic manufacturing capacity forces Africa to import 99% of its vaccine needs.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>Moderna patent application raises fears for Africa COVID vaccine hub</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna patent application raises fears for Africa COVID vaccine hub\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-02-17 19:03</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>* Africa hub firm says patent will impede freedom to operate</p><p>* Moderna says patents will not affect vaccine distribution</p><p>* Firm has pledged not to enforce mRNA patents during pandemic</p><p>* But charities fear it will, once COVID-19 is declared endemic</p><p>CAPE TOWN/CHICAGO, Feb 17 (Reuters) - Moderna Inc has applied for patents in South Africa relating to its COVID-19 vaccine, prompting fears the company could eventually seek to prevent a new African vaccine manufacturing hub from making its own version of the mRNA shot.</p><p>Moderna    spokesperson Colleen Hussey confirmed it had filed for patents \"related to both the COVID-19 vaccine and Moderna's platform technology\" in South Africa and elsewhere, after a group of 60 Africa-based charities raised concerns about them, but said the move would not block vaccine distribution in Africa.</p><p>She reiterated Moderna's October 2020 pledge not to enforce its COVID-19 related patents during the coronavirus pandemic.</p><p>But South Africa's Afrigen Biologics, which used the publicly available sequence of Moderna's vaccine to make its own version of the vaccine, said it had received no communication from the company about the patent filings.</p><p>It plans to start making and distributing across Africa in November.</p><p>Responding to a query if the company would enforce patents in Africa at the end of the pandemic, Chief Executive Stéphane Bancel told Reuters, \"We have not decided yet for low- and middle-income countries.\"</p><p>The charities fear it will enforce them when COVID-19 is declared endemic, Tian Johnson, founder of the African Alliance, said in a joint statement.</p><p>This \"would effectively derail all work the World Health Organization and African scientists have put into building vaccine manufacturing capacity on the continent,\" he added.</p><p>The Africa vaccine hub has WHO backing, as part of a pilot project to give poor and middle-income countries the know-how to make COVID-19 vaccines.</p><p>\"Moderna is committed to ... equitable access to vaccines and can confirm that its intellectual property will not create a barrier to COVID vaccine distribution in AMC-92 countries by Afrigen Biologics either now or in the future,\" Hussey said.</p><p>But Afrigen Chief Executive Petro Terblanche told Reuters in a text message, \"We have had no communication from Moderna ... We (would) ... truly value their collaboration.\"</p><p>\"There are patents filed in South Africa and other low-and-middle income countries by Moderna that, unless those are revoked, or voluntary licenses are awarded or Moderna will waive it, it will impact on our freedom to operate,\" she added.</p><p>On Wednesday, BioNTech's     co-founder and top executive told Reuters the vaccine maker had no plans to enforce its intellectual property rights should groups in Africa seek to make unauthorised versions of its shot.</p><p>For much of the pandemic, wealthy countries monopolised most of the global supplies of vaccines, leaving Africa massively under-vaccinated, with just <a href=\"https://laohu8.com/S/AONE.U\">one</a> in ten Africans immunised.</p><p>Poor domestic manufacturing capacity forces Africa to import 99% of its vaccine needs.</p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","BK4534":"瑞士信贷持仓","BK4535":"淡马锡持仓","BK4139":"生物科技","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4568":"美国抗疫概念","BK4532":"文艺复兴科技持仓","MRNA":"Moderna, Inc.","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2212613232","content_text":"* Africa hub firm says patent will impede freedom to operate* Moderna says patents will not affect vaccine distribution* Firm has pledged not to enforce mRNA patents during pandemic* But charities fear it will, once COVID-19 is declared endemicCAPE TOWN/CHICAGO, Feb 17 (Reuters) - Moderna Inc has applied for patents in South Africa relating to its COVID-19 vaccine, prompting fears the company could eventually seek to prevent a new African vaccine manufacturing hub from making its own version of the mRNA shot.Moderna    spokesperson Colleen Hussey confirmed it had filed for patents \"related to both the COVID-19 vaccine and Moderna's platform technology\" in South Africa and elsewhere, after a group of 60 Africa-based charities raised concerns about them, but said the move would not block vaccine distribution in Africa.She reiterated Moderna's October 2020 pledge not to enforce its COVID-19 related patents during the coronavirus pandemic.But South Africa's Afrigen Biologics, which used the publicly available sequence of Moderna's vaccine to make its own version of the vaccine, said it had received no communication from the company about the patent filings.It plans to start making and distributing across Africa in November.Responding to a query if the company would enforce patents in Africa at the end of the pandemic, Chief Executive Stéphane Bancel told Reuters, \"We have not decided yet for low- and middle-income countries.\"The charities fear it will enforce them when COVID-19 is declared endemic, Tian Johnson, founder of the African Alliance, said in a joint statement.This \"would effectively derail all work the World Health Organization and African scientists have put into building vaccine manufacturing capacity on the continent,\" he added.The Africa vaccine hub has WHO backing, as part of a pilot project to give poor and middle-income countries the know-how to make COVID-19 vaccines.\"Moderna is committed to ... equitable access to vaccines and can confirm that its intellectual property will not create a barrier to COVID vaccine distribution in AMC-92 countries by Afrigen Biologics either now or in the future,\" Hussey said.But Afrigen Chief Executive Petro Terblanche told Reuters in a text message, \"We have had no communication from Moderna ... We (would) ... truly value their collaboration.\"\"There are patents filed in South Africa and other low-and-middle income countries by Moderna that, unless those are revoked, or voluntary licenses are awarded or Moderna will waive it, it will impact on our freedom to operate,\" she added.On Wednesday, BioNTech's     co-founder and top executive told Reuters the vaccine maker had no plans to enforce its intellectual property rights should groups in Africa seek to make unauthorised versions of its shot.For much of the pandemic, wealthy countries monopolised most of the global supplies of vaccines, leaving Africa massively under-vaccinated, with just one in ten Africans immunised.Poor domestic manufacturing capacity forces Africa to import 99% of its vaccine needs.","news_type":1},"isVote":1,"tweetType":1,"viewCount":630,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9092174101,"gmtCreate":1644570816898,"gmtModify":1676533942239,"author":{"id":"3579666066637422","authorId":"3579666066637422","name":"Hodl","avatar":"https://static.tigerbbs.com/d591a82f579d3114da9795812a4217a0","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579666066637422","authorIdStr":"3579666066637422"},"themes":[],"htmlText":"[Cool]&nbsp;","listText":"[Cool]&nbsp;","text":"[Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9092174101","repostId":"1157713262","repostType":4,"isVote":1,"tweetType":1,"viewCount":713,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9098044129,"gmtCreate":1643985176359,"gmtModify":1676533878712,"author":{"id":"3579666066637422","authorId":"3579666066637422","name":"Hodl","avatar":"https://static.tigerbbs.com/d591a82f579d3114da9795812a4217a0","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579666066637422","authorIdStr":"3579666066637422"},"themes":[],"htmlText":"[Grin]&nbsp;","listText":"[Grin]&nbsp;","text":"[Grin]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9098044129","repostId":"2208312962","repostType":4,"isVote":1,"tweetType":1,"viewCount":735,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9093726879,"gmtCreate":1643715709348,"gmtModify":1676533847663,"author":{"id":"3579666066637422","authorId":"3579666066637422","name":"Hodl","avatar":"https://static.tigerbbs.com/d591a82f579d3114da9795812a4217a0","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579666066637422","authorIdStr":"3579666066637422"},"themes":[],"htmlText":"[What]&nbsp;","listText":"[What]&nbsp;","text":"[What]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9093726879","repostId":"1109327372","repostType":4,"isVote":1,"tweetType":1,"viewCount":714,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9093317253,"gmtCreate":1643516456506,"gmtModify":1676533827875,"author":{"id":"3579666066637422","authorId":"3579666066637422","name":"Hodl","avatar":"https://static.tigerbbs.com/d591a82f579d3114da9795812a4217a0","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579666066637422","authorIdStr":"3579666066637422"},"themes":[],"htmlText":"[Grin]&nbsp;","listText":"[Grin]&nbsp;","text":"[Grin]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9093317253","repostId":"2207801217","repostType":4,"isVote":1,"tweetType":1,"viewCount":983,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9099910412,"gmtCreate":1643289012478,"gmtModify":1676533797075,"author":{"id":"3579666066637422","authorId":"3579666066637422","name":"Hodl","avatar":"https://static.tigerbbs.com/d591a82f579d3114da9795812a4217a0","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579666066637422","authorIdStr":"3579666066637422"},"themes":[],"htmlText":"[Surprised]&nbsp;","listText":"[Surprised]&nbsp;","text":"[Surprised]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9099910412","repostId":"1115698107","repostType":4,"repost":{"id":"1115698107","kind":"news","pubTimestamp":1643288624,"share":"https://ttm.financial/m/news/1115698107?lang=&edition=full_marsco","pubTime":"2022-01-27 21:03","market":"us","language":"en","title":"Tesla Delays New Models in Bet Thin Lineup Can Ease Supply Woes","url":"https://stock-news.laohu8.com/highlight/detail?id=1115698107","media":"Bloomberg","summary":"Tesla Inc. pushed back introductions of new models to next year, wagering the best way to continue e","content":"<html><head></head><body><p>Tesla Inc. pushed back introductions of new models to next year, wagering the best way to continue expanding sales in the face of supply-chain challenges will be to further leverage a narrow lineup of big sellers.</p><p>The world’s most valuable automaker will focus on scaling up production in 2022 to follow up what Chief Executive Officer <a class=\"promotion-word\" href=\"https://ttm.financial/U/4197425891462882\">Elon Musk</a> called a breakthrough year both for Tesla and electric cars in general. Relying on just two vehicles -- the Model 3 and Y -- for 97% of deliveries helped alleviate challenges led by the semiconductor shortage crimping output across the car industry.</p><p>“Both last year and this year, if we were to introduce new vehicles, our total vehicle output would decrease,” <a class=\"promotion-word\" href=\"https://ttm.financial/U/4197425891462882\">Musk</a> said late Wednesday after Tesla reported record revenue and earnings per share, both of which beat analysts’ estimates. Rolling out the Cybertruck, Semi or Roadster in 2022 “would not make any sense because we’ll still be parts-constrained.”</p><p>While having to procure chips for just a handful of models has been an advantage for Tesla, putting off launches of new products carries some risk. Rivian Automotive Inc. is ramping up production of its R1T electric pickup, and truck-segment leader Ford Motor Co. is coming to market with a plug-in version of its best-selling F-150 in the coming months.</p><p>Tesla shares fell as much as 2% to $919 before the start of regular trading Thursday in New York. The stock advanced 50% last year after soaring 743% in 2020.</p><p>“TSLA shares tend to work the best when something new is coming,” Jeffrey Osborne, a Cowen & Co. analyst with the equivalent of a hold rating on the stock, said in a note.</p><p>Lacking near-term additions to Tesla showrooms to promote, <a class=\"promotion-word\" href=\"https://ttm.financial/U/4197425891462882\">Musk</a> spent much of Tesla’s earnings call discussing the potential of self-driving technology and a humanoid robot the company has under development.</p><p>While Tesla has for years charged thousands of dollars for Full Self-Driving capability that it has said will live up to that name sometime in the future, the features are still in beta and humans must continue minding the steering wheel.</p><p><a class=\"promotion-word\" href=\"https://ttm.financial/U/4197425891462882\">Musk</a> said the robot he first teased five months ago may be the most important product the carmaker is working on and has the potential to be more significant than its vehicle business.</p><p>That will be a tall order, at least from an earnings perspective. Automotive revenue soared to almost $16 billion in the fourth quarter and was 90% of total sales. Profit excluding some items jumped to $2.54 a share, beating analysts’ average estimate for $2.36 a share.</p><p>Tesla delivered more than 936,000 vehicles worldwide in 2021, up 87% from the year before and exceeding the 50% average annual expansion projected over several years. While <a class=\"promotion-word\" href=\"https://ttm.financial/U/4197425891462882\">Musk</a> expects to comfortably exceed that growth again in 2022, the company warned its factories are likely to continue running below capacity through this year because of supply-chain issues.</p><p>“The commentary on the risk factors is taking on a different weight in the current environment,” said Gene Munster, a co-founder of investment firm Loup Ventures. “Whenever there are unknowns about the future it can spook investors a little bit.”</p><p>After sitting out Tesla’s earnings call last quarter, Musk returned Wednesday to explain the decision to further delay models he first showed prototypes of as far back as 2017.</p><p>Tesla will do engineering and tooling work this year to get the Cybertruck, Semi and Roadster ready for production, “hopefully next year,” Musk said. The company isn’t currently working on a $25,000 vehicle that he said in 2020 Tesla would try to make in roughly three years.</p><p>“We have enough on our plate right now, too much on our plates, frankly,” Musk said. “The thing that overwhelmingly matters is when is the car autonomous.”</p><p>Tesla’s Full Self-Driving capability will become the most important source of profitability for the company over time, he said.</p><p>With last year’s net income of $5.5 billion on a generally accepted accounting principles basis, Tesla clinched a milestone that its CEO touted toward the beginning of the call.</p><p>“Our accumulated profitability since the inception of the company became positive, which I think makes us a real company at this point,” Musk said.</p></body></html>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>Tesla Delays New Models in Bet Thin Lineup Can Ease Supply Woes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Delays New Models in Bet Thin Lineup Can Ease Supply Woes\n</h2>\n<h4 class=\"meta\">\n\n\n2022-01-27 21:03 GMT+8   <a href=\"https://finance.yahoo.com/news/tesla-beats-fourth-quarter-estimates-222259665.html\"><strong>Bloomberg</strong></a>\n</h4>\n</header>\n<article>\n<div>\n<p>Tesla Inc. pushed back introductions of new models to next year, wagering the best way to continue expanding sales in the face of supply-chain challenges will be to further leverage a narrow lineup of...</p>\n<a href=\"https://finance.yahoo.com/news/tesla-beats-fourth-quarter-estimates-222259665.html\">Web Link</a>\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://finance.yahoo.com/news/tesla-beats-fourth-quarter-estimates-222259665.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1115698107","content_text":"Tesla Inc. pushed back introductions of new models to next year, wagering the best way to continue expanding sales in the face of supply-chain challenges will be to further leverage a narrow lineup of big sellers.The world’s most valuable automaker will focus on scaling up production in 2022 to follow up what Chief Executive Officer Elon Musk called a breakthrough year both for Tesla and electric cars in general. Relying on just two vehicles -- the Model 3 and Y -- for 97% of deliveries helped alleviate challenges led by the semiconductor shortage crimping output across the car industry.“Both last year and this year, if we were to introduce new vehicles, our total vehicle output would decrease,” Musk said late Wednesday after Tesla reported record revenue and earnings per share, both of which beat analysts’ estimates. Rolling out the Cybertruck, Semi or Roadster in 2022 “would not make any sense because we’ll still be parts-constrained.”While having to procure chips for just a handful of models has been an advantage for Tesla, putting off launches of new products carries some risk. Rivian Automotive Inc. is ramping up production of its R1T electric pickup, and truck-segment leader Ford Motor Co. is coming to market with a plug-in version of its best-selling F-150 in the coming months.Tesla shares fell as much as 2% to $919 before the start of regular trading Thursday in New York. The stock advanced 50% last year after soaring 743% in 2020.“TSLA shares tend to work the best when something new is coming,” Jeffrey Osborne, a Cowen & Co. analyst with the equivalent of a hold rating on the stock, said in a note.Lacking near-term additions to Tesla showrooms to promote, Musk spent much of Tesla’s earnings call discussing the potential of self-driving technology and a humanoid robot the company has under development.While Tesla has for years charged thousands of dollars for Full Self-Driving capability that it has said will live up to that name sometime in the future, the features are still in beta and humans must continue minding the steering wheel.Musk said the robot he first teased five months ago may be the most important product the carmaker is working on and has the potential to be more significant than its vehicle business.That will be a tall order, at least from an earnings perspective. Automotive revenue soared to almost $16 billion in the fourth quarter and was 90% of total sales. Profit excluding some items jumped to $2.54 a share, beating analysts’ average estimate for $2.36 a share.Tesla delivered more than 936,000 vehicles worldwide in 2021, up 87% from the year before and exceeding the 50% average annual expansion projected over several years. While Musk expects to comfortably exceed that growth again in 2022, the company warned its factories are likely to continue running below capacity through this year because of supply-chain issues.“The commentary on the risk factors is taking on a different weight in the current environment,” said Gene Munster, a co-founder of investment firm Loup Ventures. “Whenever there are unknowns about the future it can spook investors a little bit.”After sitting out Tesla’s earnings call last quarter, Musk returned Wednesday to explain the decision to further delay models he first showed prototypes of as far back as 2017.Tesla will do engineering and tooling work this year to get the Cybertruck, Semi and Roadster ready for production, “hopefully next year,” Musk said. The company isn’t currently working on a $25,000 vehicle that he said in 2020 Tesla would try to make in roughly three years.“We have enough on our plate right now, too much on our plates, frankly,” Musk said. “The thing that overwhelmingly matters is when is the car autonomous.”Tesla’s Full Self-Driving capability will become the most important source of profitability for the company over time, he said.With last year’s net income of $5.5 billion on a generally accepted accounting principles basis, Tesla clinched a milestone that its CEO touted toward the beginning of the call.“Our accumulated profitability since the inception of the company became positive, which I think makes us a real company at this point,” Musk said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":917,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9090191654,"gmtCreate":1643108100031,"gmtModify":1676533774554,"author":{"id":"3579666066637422","authorId":"3579666066637422","name":"Hodl","avatar":"https://static.tigerbbs.com/d591a82f579d3114da9795812a4217a0","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579666066637422","authorIdStr":"3579666066637422"},"themes":[],"htmlText":"[Cry]&nbsp;","listText":"[Cry]&nbsp;","text":"[Cry]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9090191654","repostId":"1179412375","repostType":4,"repost":{"id":"1179412375","kind":"news","pubTimestamp":1643105755,"share":"https://ttm.financial/m/news/1179412375?lang=&edition=full_marsco","pubTime":"2022-01-25 18:15","market":"us","language":"en","title":"Nvidia Quietly Prepares to Abandon Takeover of Arm","url":"https://stock-news.laohu8.com/highlight/detail?id=1179412375","media":"Bloomberg","summary":"Nvidia Corp.is quietly preparing to abandon its purchase of Arm Ltd.from SoftBank Group Corp.after m","content":"<html><head></head><body><p>Nvidia Corp.is quietly preparing to abandon its purchase of Arm Ltd.from SoftBank Group Corp.after making little to no progress in winning approval for the $40 billion chip deal, according to people familiar with the matter.</p><p>Nvidia has told partners that it doesn’t expect the transaction to close, according to one person, who asked not to be identified because the discussions are private. SoftBank, meanwhile, is stepping up preparations for an Arm initial public offering as an alternative to the Nvidia takeover, another person said.</p><p>The purchase -- poised to become the biggest semiconductor deal in history when it was announced in September 2020 -- has drawn a fierce backlash from regulators and the chip industry, including Arm’s own customers. The U.S. Federal Trade Commission sued to stop the transaction in December, arguing that Nvidia would become too powerful if it gained control over Arm’s chip designs.</p></body></html>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>Nvidia Quietly Prepares to Abandon Takeover of Arm</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNvidia Quietly Prepares to Abandon Takeover of Arm\n</h2>\n<h4 class=\"meta\">\n\n\n2022-01-25 18:15 GMT+8   <a href=\"https://www.bloomberg.com/news/articles/2022-01-25/nvidia-is-said-to-quietly-prepare-to-abandon-takeover-of-arm?utm_source=google&utm_medium=bd&cmpId=google\"><strong>Bloomberg</strong></a>\n</h4>\n</header>\n<article>\n<div>\n<p>Nvidia Corp.is quietly preparing to abandon its purchase of Arm Ltd.from SoftBank Group Corp.after making little to no progress in winning approval for the $40 billion chip deal, according to people ...</p>\n<a href=\"https://www.bloomberg.com/news/articles/2022-01-25/nvidia-is-said-to-quietly-prepare-to-abandon-takeover-of-arm?utm_source=google&utm_medium=bd&cmpId=google\">Web Link</a>\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVDA":"英伟达"},"source_url":"https://www.bloomberg.com/news/articles/2022-01-25/nvidia-is-said-to-quietly-prepare-to-abandon-takeover-of-arm?utm_source=google&utm_medium=bd&cmpId=google","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1179412375","content_text":"Nvidia Corp.is quietly preparing to abandon its purchase of Arm Ltd.from SoftBank Group Corp.after making little to no progress in winning approval for the $40 billion chip deal, according to people familiar with the matter.Nvidia has told partners that it doesn’t expect the transaction to close, according to one person, who asked not to be identified because the discussions are private. SoftBank, meanwhile, is stepping up preparations for an Arm initial public offering as an alternative to the Nvidia takeover, another person said.The purchase -- poised to become the biggest semiconductor deal in history when it was announced in September 2020 -- has drawn a fierce backlash from regulators and the chip industry, including Arm’s own customers. The U.S. Federal Trade Commission sued to stop the transaction in December, arguing that Nvidia would become too powerful if it gained control over Arm’s chip designs.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1143,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9007737388,"gmtCreate":1643002725654,"gmtModify":1676533764196,"author":{"id":"3579666066637422","authorId":"3579666066637422","name":"Hodl","avatar":"https://static.tigerbbs.com/d591a82f579d3114da9795812a4217a0","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579666066637422","authorIdStr":"3579666066637422"},"themes":[],"htmlText":"[Grin]&nbsp;","listText":"[Grin]&nbsp;","text":"[Grin]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9007737388","repostId":"1137230014","repostType":4,"repost":{"id":"1137230014","kind":"news","pubTimestamp":1643001525,"share":"https://ttm.financial/m/news/1137230014?lang=&edition=full_marsco","pubTime":"2022-01-24 13:18","market":"us","language":"en","title":"Peloton may be toast","url":"https://stock-news.laohu8.com/highlight/detail?id=1137230014","media":"CNN Business","summary":"New York (CNN Business) - Peloton had a disastrous 2021. But as impossible as it may seem, the exerc","content":"<html><head></head><body><p><b>New York (CNN Business) - </b>Peloton had a disastrous 2021. But as impossible as it may seem, the exercise equipment company is arguably off to an even worse start to 2022.</p><p>Shares of Peloton(PTON) are down nearly 25% this year and trading at their lowest level in nearly two years. The stock was up 12% Friday though after the company confirmed late Thursday that it may be looking to slow production of its bikes and treadmills and potentially lay off workers.</p><p>The news came after CNBC reported Peloton was considering pausing production of its low-end bike (which still costs $1,495) for two months. Peloton CEO John Foley, while not referring to CNBC specifically, categorized \"rumors that we are halting all production of bikes and Treads\" as \"false.\"</p><p>So can Peloton be fixed?If the stock continues to slide, there may be more pressure on the company to restructure further, or potentially even look for a buyer. Peloton did not respond to requests for comment.</p><p>Peloton shares plunged more than 75% in 2021 as the once red-hot stock (it soared nearly 400% in 2020) spun out of control. The company has gone from being a pandemic-era stay-at-home darling to one that is constantly having to put out PR fires.</p><p>Product recalls have hurt the company's image and its sales.The high prices for its equipment also don't help. Competition from upstarts selling much cheaper bikes has eaten into sales, as not everyone that wants to work out is a wealthy suburbanite with plenty of disposable cash to spend.</p><p>Peloton has nearly 6 million subscribers, many of which are loyal. But make no mistake: This is still a high-end, niche company.</p><p>Peloton has also been hurt by the fact that more people have started to go back to the gym as the pandemic has worn on, especially now that millions of Americans are vaccinated and boosted for Covid-19.</p><p>It's been so bad that Peloton even suffered a brief stock drop after the fictitious Mr. Big character from \"Sex and the City\" died after using a Peloton on the show's new HBO Max streaming reboot. (HBO Max, like CNN, is a part ofAT&T's(T)WarnerMedia division.)</p><p>Peloton tried to \"spin\" this story by running a tongue in cheek ad featuring Mr. Big actor Chris Noth, but even that backfired after Noth was subsequently accused of sexual assault my multiple women. Peloton has stopped touting the viral ad.</p><p>Several insiders have been selling stock in the past year, too. Even though many of the stock sales are part of pre-arranged plans, the optics certainly aren't great.</p><p>The company continues to lose money and it is expected to post more red ink in its next fiscal year as well.</p><p><b>The road ahead doesn't look too promising</b></p><p>Peloton faces an uphill climb. Many analysts have soured on the firm. While 15 still have \"buy\" ratings on the stock, fourteen have a lukewarm \"hold\" on Peloton and two even have \"sell\" recommendations,</p><p>\"Peloton is hoping that future sales benefit from lowering prices of its entry-level Bike to $1,495, which we think is a show-me story,\" said CFRA analyst Kenneth Leon in a report on the stock last month. He has a \"hold\" on Peloton, calling it a \"broken growth stock.\"</p><p>One also has to wonder if Peloton might be better off as a private company or if a larger publicly traded firm could swoop in to take it over.</p><p>Just this week, troubled video game company Activision Blizzard (ATVI), which has been accused of having a toxic workplace culture riddled with harassment, found a savior in Microsoft (MSFT).</p><p>It's not clear who exactly would be a good fit for Peloton.Apple (AAPL) is occasionally mentioned as a possible suitor, which could make sense given that the Apple Watch powers the company's Apple Fitness+ app.</p><p>But at least one investing firm thinks Peloton should actually go on the offensive and make an acquisition of its own in order to try and diversify. Citron Research, run by noted short seller Andrew Left, believes meal kit companyBlue Apron (APRN) could make sense as a Peloton purchase.</p><p>\"The company most likely to acquire Blue Apron is Peloton. Peloton is facing the dilemma of how to grow its subscription revenue and the answer is to sell your customers more items,\" said Citron in a bullish report Thursday about Blue Apron. (Not every Citron recommendation is a sell.)</p><p>\"Peloton wants to be known as a health and wellness company, not a fitness business. Peloton sells a lifestyle and the two key components of a healthy lifestyle are diet and exercise,\" Citron added.</p><p>Blue Apron had no comment on the Citron report.</p><p>Peloton's woes are also hurting the once trendy \"buy now, pay later\" stock Affirm, which lists Peloton as its biggest customer.Affirm said in its annual report that Peloton accounted for about 20% of its sales last year.</p><p>Affirm, along with other companies in the BNPL market, have already been hurt by worries of a regulatory crackdown on the industry, which lets people pay in installments for online purchases. Shares of Affirm are down nearly 40% this year and have fallen more than 10% this week.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>Peloton may be toast</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPeloton may be toast\n</h2>\n<h4 class=\"meta\">\n\n\n2022-01-24 13:18 GMT+8   <a href=\"https://edition.cnn.com/2022/01/21/investing/peloton-analysis-stock/index.html\"><strong>CNN Business</strong></a>\n</h4>\n</header>\n<article>\n<div>\n<p>New York (CNN Business) - Peloton had a disastrous 2021. But as impossible as it may seem, the exercise equipment company is arguably off to an even worse start to 2022.Shares of Peloton(PTON) are ...</p>\n<a href=\"https://edition.cnn.com/2022/01/21/investing/peloton-analysis-stock/index.html\">Web Link</a>\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PTON":"Peloton Interactive, Inc."},"source_url":"https://edition.cnn.com/2022/01/21/investing/peloton-analysis-stock/index.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1137230014","content_text":"New York (CNN Business) - Peloton had a disastrous 2021. But as impossible as it may seem, the exercise equipment company is arguably off to an even worse start to 2022.Shares of Peloton(PTON) are down nearly 25% this year and trading at their lowest level in nearly two years. The stock was up 12% Friday though after the company confirmed late Thursday that it may be looking to slow production of its bikes and treadmills and potentially lay off workers.The news came after CNBC reported Peloton was considering pausing production of its low-end bike (which still costs $1,495) for two months. Peloton CEO John Foley, while not referring to CNBC specifically, categorized \"rumors that we are halting all production of bikes and Treads\" as \"false.\"So can Peloton be fixed?If the stock continues to slide, there may be more pressure on the company to restructure further, or potentially even look for a buyer. Peloton did not respond to requests for comment.Peloton shares plunged more than 75% in 2021 as the once red-hot stock (it soared nearly 400% in 2020) spun out of control. The company has gone from being a pandemic-era stay-at-home darling to one that is constantly having to put out PR fires.Product recalls have hurt the company's image and its sales.The high prices for its equipment also don't help. Competition from upstarts selling much cheaper bikes has eaten into sales, as not everyone that wants to work out is a wealthy suburbanite with plenty of disposable cash to spend.Peloton has nearly 6 million subscribers, many of which are loyal. But make no mistake: This is still a high-end, niche company.Peloton has also been hurt by the fact that more people have started to go back to the gym as the pandemic has worn on, especially now that millions of Americans are vaccinated and boosted for Covid-19.It's been so bad that Peloton even suffered a brief stock drop after the fictitious Mr. Big character from \"Sex and the City\" died after using a Peloton on the show's new HBO Max streaming reboot. (HBO Max, like CNN, is a part ofAT&T's(T)WarnerMedia division.)Peloton tried to \"spin\" this story by running a tongue in cheek ad featuring Mr. Big actor Chris Noth, but even that backfired after Noth was subsequently accused of sexual assault my multiple women. Peloton has stopped touting the viral ad.Several insiders have been selling stock in the past year, too. Even though many of the stock sales are part of pre-arranged plans, the optics certainly aren't great.The company continues to lose money and it is expected to post more red ink in its next fiscal year as well.The road ahead doesn't look too promisingPeloton faces an uphill climb. Many analysts have soured on the firm. While 15 still have \"buy\" ratings on the stock, fourteen have a lukewarm \"hold\" on Peloton and two even have \"sell\" recommendations,\"Peloton is hoping that future sales benefit from lowering prices of its entry-level Bike to $1,495, which we think is a show-me story,\" said CFRA analyst Kenneth Leon in a report on the stock last month. He has a \"hold\" on Peloton, calling it a \"broken growth stock.\"One also has to wonder if Peloton might be better off as a private company or if a larger publicly traded firm could swoop in to take it over.Just this week, troubled video game company Activision Blizzard (ATVI), which has been accused of having a toxic workplace culture riddled with harassment, found a savior in Microsoft (MSFT).It's not clear who exactly would be a good fit for Peloton.Apple (AAPL) is occasionally mentioned as a possible suitor, which could make sense given that the Apple Watch powers the company's Apple Fitness+ app.But at least one investing firm thinks Peloton should actually go on the offensive and make an acquisition of its own in order to try and diversify. Citron Research, run by noted short seller Andrew Left, believes meal kit companyBlue Apron (APRN) could make sense as a Peloton purchase.\"The company most likely to acquire Blue Apron is Peloton. Peloton is facing the dilemma of how to grow its subscription revenue and the answer is to sell your customers more items,\" said Citron in a bullish report Thursday about Blue Apron. (Not every Citron recommendation is a sell.)\"Peloton wants to be known as a health and wellness company, not a fitness business. Peloton sells a lifestyle and the two key components of a healthy lifestyle are diet and exercise,\" Citron added.Blue Apron had no comment on the Citron report.Peloton's woes are also hurting the once trendy \"buy now, pay later\" stock Affirm, which lists Peloton as its biggest customer.Affirm said in its annual report that Peloton accounted for about 20% of its sales last year.Affirm, along with other companies in the BNPL market, have already been hurt by worries of a regulatory crackdown on the industry, which lets people pay in installments for online purchases. Shares of Affirm are down nearly 40% this year and have fallen more than 10% this week.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1169,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9007883879,"gmtCreate":1642824120779,"gmtModify":1676533750764,"author":{"id":"3579666066637422","authorId":"3579666066637422","name":"Hodl","avatar":"https://static.tigerbbs.com/d591a82f579d3114da9795812a4217a0","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579666066637422","authorIdStr":"3579666066637422"},"themes":[],"htmlText":"[Grin]&nbsp;","listText":"[Grin]&nbsp;","text":"[Grin]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9007883879","repostId":"2205302378","repostType":4,"isVote":1,"tweetType":1,"viewCount":859,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9007883345,"gmtCreate":1642824069225,"gmtModify":1676533750748,"author":{"id":"3579666066637422","authorId":"3579666066637422","name":"Hodl","avatar":"https://static.tigerbbs.com/d591a82f579d3114da9795812a4217a0","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579666066637422","authorIdStr":"3579666066637422"},"themes":[],"htmlText":"[Grin]&nbsp;","listText":"[Grin]&nbsp;","text":"[Grin]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9007883345","repostId":"2205302378","repostType":4,"repost":{"id":"2205302378","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1642800688,"share":"https://ttm.financial/m/news/2205302378?lang=&edition=full_marsco","pubTime":"2022-01-22 05:31","market":"us","language":"en","title":"US STOCKS-S&P 500, Nasdaq Post Worst Weeks since Pandemic Start as Netflix Woes Deepen Slide","url":"https://stock-news.laohu8.com/highlight/detail?id=2205302378","media":"Reuters","summary":"* Netflix plunges, weighs on Disney, media stocks* S&P 500, Nasdaq have biggest weekly drops since March 2020* Focus turning to Fed meeting for clarity on policy* Indexes down: Dow 1.3%, S&P 1.89%, Na","content":"<html><head></head><body><p>* Netflix plunges, weighs on Disney, media stocks</p><p>* S&P 500, Nasdaq have biggest weekly drops since March 2020</p><p>* Focus turning to Fed meeting for clarity on policy</p><p>* Indexes down: Dow 1.3%, S&P 1.89%, Nasdaq 2.72%</p><p>Jan 21 (Reuters) - Wall Street's main indexes ended sharply lower on Friday as Netflix shares plunged after a weak earnings report, capping a brutal week for stocks that saw the S&P 500 and Nasdaq log their  biggest weekly percentage drops since the onset of the pandemic in March 2020.</p><p>The benchmark S&P 500 posted its third straight week of declines, ending 8.3% down from its early January record high.</p><p>Losses also deepened for the Nasdaq after the tech-heavy index earlier in the week confirmed it was in a correction, closing down over 10% from its November peak. The Nasdaq has now fallen 14.3% from its November peak and on Friday closed at its lowest level since June.</p><p>Netflix    shares tumbled 21.8%, weighing on the S&P 500 and the Nasdaq, after the streaming giant forecast weak subscriber growth. Shares of competitor Walt Disney    fell 6.9%, dragging on the Dow, while Roku    also slid 9.1%.</p><p>\"It has really been a continuation of a tech rout,” said Paul Nolte, portfolio manager at Kingsview Investment Management. \"It’s really a combination of a rotation out of technology as well as very poor numbers from Netflix that I think is the catalyst for today.\"</p><p>The Dow Jones Industrial Average    fell 450.02 points, or 1.3%, to 34,265.37, the S&P 500    lost 84.79 points, or 1.89%, to 4,397.94 and the Nasdaq Composite    dropped 385.10 points, or 2.72%, to 13,768.92.</p><p>For the week, the S&P 500 fell 5.7%, the Dow dropped 4.6% and the Nasdaq declined 7.6%.</p><p>The Dow fell for a sixth straight session, its longest streak of daily declines since February 2020.</p><p>The S&P 500 closed below its 200-day moving average, a key technical level, for the first time since June 2020.</p><p>\"When markets get like they've gotten this week, the emotion is what takes over,\" said Jim Paulsen, chief investment strategist at The Leuthold Group. \"Until it finds support, no <a href=\"https://laohu8.com/S/AONE.U\">one</a>'s going care about anything fundamental.\"</p><p>Stocks are off to a rough start in 2022, as a fast rise in Treasury yields amid concerns the Federal Reserve will become aggressive in controlling inflation has particularly hit tech and growth shares.</p><p>Investors are keenly focused on next week's Fed meeting for more clarity on the central bank's plans to tighten monetary policy in the coming months, after data last week showed U.S. consumer prices in December had the largest annual rise in nearly four decades.</p><p>“Between the Fed meeting and earnings, there is a lot that the market could be worried about next week,” said Anu Gaggar, global investment strategist at Commonwealth Financial Network.</p><p>Apple   , Tesla    and Microsoft    are among the large companies due to report next week in a busy week of earnings results.</p><p>Declining issues outnumbered advancing ones on the NYSE by a 4.26-to-1 ratio; on Nasdaq, a 4.34-to-1 ratio favored decliners.</p><p>The S&P 500 posted five new 52-week highs and 24 new lows; the Nasdaq Composite recorded 13 new highs and 1,029 new lows.</p><p>About 14.6 billion shares changed hands in U.S. exchanges, compared with the 10.4 billion daily average over the last 20 sessions.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>US STOCKS-S&P 500, Nasdaq Post Worst Weeks since Pandemic Start as Netflix Woes Deepen Slide</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS STOCKS-S&P 500, Nasdaq Post Worst Weeks since Pandemic Start as Netflix Woes Deepen Slide\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-01-22 05:31</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>* Netflix plunges, weighs on Disney, media stocks</p><p>* S&P 500, Nasdaq have biggest weekly drops since March 2020</p><p>* Focus turning to Fed meeting for clarity on policy</p><p>* Indexes down: Dow 1.3%, S&P 1.89%, Nasdaq 2.72%</p><p>Jan 21 (Reuters) - Wall Street's main indexes ended sharply lower on Friday as Netflix shares plunged after a weak earnings report, capping a brutal week for stocks that saw the S&P 500 and Nasdaq log their  biggest weekly percentage drops since the onset of the pandemic in March 2020.</p><p>The benchmark S&P 500 posted its third straight week of declines, ending 8.3% down from its early January record high.</p><p>Losses also deepened for the Nasdaq after the tech-heavy index earlier in the week confirmed it was in a correction, closing down over 10% from its November peak. The Nasdaq has now fallen 14.3% from its November peak and on Friday closed at its lowest level since June.</p><p>Netflix    shares tumbled 21.8%, weighing on the S&P 500 and the Nasdaq, after the streaming giant forecast weak subscriber growth. Shares of competitor Walt Disney    fell 6.9%, dragging on the Dow, while Roku    also slid 9.1%.</p><p>\"It has really been a continuation of a tech rout,” said Paul Nolte, portfolio manager at Kingsview Investment Management. \"It’s really a combination of a rotation out of technology as well as very poor numbers from Netflix that I think is the catalyst for today.\"</p><p>The Dow Jones Industrial Average    fell 450.02 points, or 1.3%, to 34,265.37, the S&P 500    lost 84.79 points, or 1.89%, to 4,397.94 and the Nasdaq Composite    dropped 385.10 points, or 2.72%, to 13,768.92.</p><p>For the week, the S&P 500 fell 5.7%, the Dow dropped 4.6% and the Nasdaq declined 7.6%.</p><p>The Dow fell for a sixth straight session, its longest streak of daily declines since February 2020.</p><p>The S&P 500 closed below its 200-day moving average, a key technical level, for the first time since June 2020.</p><p>\"When markets get like they've gotten this week, the emotion is what takes over,\" said Jim Paulsen, chief investment strategist at The Leuthold Group. \"Until it finds support, no <a href=\"https://laohu8.com/S/AONE.U\">one</a>'s going care about anything fundamental.\"</p><p>Stocks are off to a rough start in 2022, as a fast rise in Treasury yields amid concerns the Federal Reserve will become aggressive in controlling inflation has particularly hit tech and growth shares.</p><p>Investors are keenly focused on next week's Fed meeting for more clarity on the central bank's plans to tighten monetary policy in the coming months, after data last week showed U.S. consumer prices in December had the largest annual rise in nearly four decades.</p><p>“Between the Fed meeting and earnings, there is a lot that the market could be worried about next week,” said Anu Gaggar, global investment strategist at Commonwealth Financial Network.</p><p>Apple   , Tesla    and Microsoft    are among the large companies due to report next week in a busy week of earnings results.</p><p>Declining issues outnumbered advancing ones on the NYSE by a 4.26-to-1 ratio; on Nasdaq, a 4.34-to-1 ratio favored decliners.</p><p>The S&P 500 posted five new 52-week highs and 24 new lows; the Nasdaq Composite recorded 13 new highs and 1,029 new lows.</p><p>About 14.6 billion shares changed hands in U.S. exchanges, compared with the 10.4 billion daily average over the last 20 sessions.</p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4566":"资本集团","BK4524":"宅经济概念","BK4559":"巴菲特持仓","BK4527":"明星科技股","BK4550":"红杉资本持仓","HUT":"Hut 8 Mining Corp","BK4551":"寇图资本持仓",".DJI":"道琼斯","SPY":"标普500ETF",".IXIC":"NASDAQ Composite","BK4504":"桥水持仓",".SPX":"S&P 500 Index","BK4548":"巴美列捷福持仓","BK4532":"文艺复兴科技持仓","NFLX":"奈飞","BK4108":"电影和娱乐","BK4507":"流媒体概念","BK4534":"瑞士信贷持仓"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2205302378","content_text":"* Netflix plunges, weighs on Disney, media stocks* S&P 500, Nasdaq have biggest weekly drops since March 2020* Focus turning to Fed meeting for clarity on policy* Indexes down: Dow 1.3%, S&P 1.89%, Nasdaq 2.72%Jan 21 (Reuters) - Wall Street's main indexes ended sharply lower on Friday as Netflix shares plunged after a weak earnings report, capping a brutal week for stocks that saw the S&P 500 and Nasdaq log their  biggest weekly percentage drops since the onset of the pandemic in March 2020.The benchmark S&P 500 posted its third straight week of declines, ending 8.3% down from its early January record high.Losses also deepened for the Nasdaq after the tech-heavy index earlier in the week confirmed it was in a correction, closing down over 10% from its November peak. The Nasdaq has now fallen 14.3% from its November peak and on Friday closed at its lowest level since June.Netflix    shares tumbled 21.8%, weighing on the S&P 500 and the Nasdaq, after the streaming giant forecast weak subscriber growth. Shares of competitor Walt Disney    fell 6.9%, dragging on the Dow, while Roku    also slid 9.1%.\"It has really been a continuation of a tech rout,” said Paul Nolte, portfolio manager at Kingsview Investment Management. \"It’s really a combination of a rotation out of technology as well as very poor numbers from Netflix that I think is the catalyst for today.\"The Dow Jones Industrial Average    fell 450.02 points, or 1.3%, to 34,265.37, the S&P 500    lost 84.79 points, or 1.89%, to 4,397.94 and the Nasdaq Composite    dropped 385.10 points, or 2.72%, to 13,768.92.For the week, the S&P 500 fell 5.7%, the Dow dropped 4.6% and the Nasdaq declined 7.6%.The Dow fell for a sixth straight session, its longest streak of daily declines since February 2020.The S&P 500 closed below its 200-day moving average, a key technical level, for the first time since June 2020.\"When markets get like they've gotten this week, the emotion is what takes over,\" said Jim Paulsen, chief investment strategist at The Leuthold Group. \"Until it finds support, no one's going care about anything fundamental.\"Stocks are off to a rough start in 2022, as a fast rise in Treasury yields amid concerns the Federal Reserve will become aggressive in controlling inflation has particularly hit tech and growth shares.Investors are keenly focused on next week's Fed meeting for more clarity on the central bank's plans to tighten monetary policy in the coming months, after data last week showed U.S. consumer prices in December had the largest annual rise in nearly four decades.“Between the Fed meeting and earnings, there is a lot that the market could be worried about next week,” said Anu Gaggar, global investment strategist at Commonwealth Financial Network.Apple   , Tesla    and Microsoft    are among the large companies due to report next week in a busy week of earnings results.Declining issues outnumbered advancing ones on the NYSE by a 4.26-to-1 ratio; on Nasdaq, a 4.34-to-1 ratio favored decliners.The S&P 500 posted five new 52-week highs and 24 new lows; the Nasdaq Composite recorded 13 new highs and 1,029 new lows.About 14.6 billion shares changed hands in U.S. exchanges, compared with the 10.4 billion daily average over the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1457,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"followers","isTTM":true}